DocSym
β
Searchsearch
Search
(D09.3) Carcinoma in situ: thyroid and other endocrine glands
More details coming soon
122 821 in individuals diagnosis carcinoma in situ: thyroid and other endocrine glands confirmed
1 183 deaths with diagnosis carcinoma in situ: thyroid and other endocrine glands
1% mortality rate associated with the disease carcinoma in situ: thyroid and other endocrine glands
Diagnosis carcinoma in situ: thyroid and other endocrine glands is diagnosed Men are 26.73% more likely than Women
77 824
Men receive the diagnosis carcinoma in situ: thyroid and other endocrine glands
1 183 (1.5 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
44 997
Women receive the diagnosis carcinoma in situ: thyroid and other endocrine glands
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease carcinoma in situ: thyroid and other endocrine glands - Men aged 60-64 and Women aged 65-69
In Men diagnosis is most often set at age 15-19, 25-94
Less common in men the disease occurs at Age 0-14, 20-24, 95+Less common in women the disease occurs at Age 0-19, 95+
In Women diagnosis is most often set at age 20-94
Disease Features carcinoma in situ: thyroid and other endocrine glands
Absence or low individual and public risk
Carcinoma in situ: thyroid and other endocrine glands - what does this mean
Carcinoma in situ of the thyroid and other endocrine glands is a form of cancer where abnormal cells are present in the inner layer of the gland, but have not yet spread to other parts of the body. it is most commonly caused by the abnormal growth of cells due to genetic mutations or environmental factors. treatment for this type of cancer typically involves surgical removal of the affected gland, and sometimes radiation therapy or chemotherapy.
What happens during the disease - carcinoma in situ: thyroid and other endocrine glands
Carcinoma in situ of the thyroid and other endocrine glands is caused by the abnormal growth of cells in the glandular tissue. this abnormal growth is caused by genetic mutations that lead to uncontrolled cell division and the accumulation of abnormal cells in the glandular tissue. this abnormal growth can cause the formation of cancerous tumors in the endocrine glands, leading to the development of carcinoma in situ.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical Exam
- Blood Tests
- Imaging Tests (Ultrasound, CT Scan, MRI)
- Biopsy
- Thyroid Function Tests
- Thyroid Hormone Levels
- Thyroid Ultrasound
- Thyroid Scan
- Thyroid Fine Needle Aspiration
Treatment and Medical Assistance
Main Goal: To reduce the risk of progression of Carcinoma in situ in the Thyroid and other endocrine glands.
- Regular monitoring and follow-up with a physician
- Surgery to remove the affected area
- Chemotherapy
- Radiation therapy
- Hormone therapy
- Immunotherapy
- Targeted therapy
10 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Carcinoma in situ: thyroid and other endocrine glands - Prevention
Carcinoma in situ of the thyroid and other endocrine glands can be prevented by avoiding exposure to environmental toxins, maintaining a healthy diet and lifestyle, and regularly undergoing medical screenings to detect any early signs of cancer. additionally, it is important to be aware of any changes in the size or shape of the thyroid or other endocrine glands, as this may be an indication of a more serious underlying condition.